Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate Patent Expiration
Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate is Used for bowel cleansing in preparation for colonoscopy in adults. It was first introduced by Salix Pharmaceuticals Inc
Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate Patents
Given below is the list of patents protecting Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Osmoprep | US5616346 | Non-aqueous colonic purgative formulations |
May 18, 2013
(Expired) | Salix Pharms |
| Osmoprep | US7687075 | Colonic purgative composition with soluble binding agent | Jun 22, 2028 | Salix Pharms |
| Visicol | US5616346 | Non-aqueous colonic purgative formulations |
May 18, 2013
(Expired) | Salix Pharms |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate Generics
Only one generic application has been filed for Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate.
Given below is the list of companies who have filed for Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate generic.
1. NOVEL LABS INC
Novel Laboratories Inc has filed for 1 generic for Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate. This 0.398gm;1.102gm version comes by the name MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE. Given below are the details of the strengths of this generic introduced by Novel Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.398GM; 1.102GM
(reference standard) | tablet | Prescription | ORAL | N/A | Dec 30, 2011 |